1. Home
  2. LYNX vs AAPG Comparison

LYNX vs AAPG Comparison

Compare LYNX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$13.59

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$15.02

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYNX
AAPG
Founded
N/A
2009
Country
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2026
2024

Fundamental Metrics

Financial Performance
Metric
LYNX
AAPG
Price
$13.59
$15.02
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.40
AVG Volume (30 Days)
434.0K
4.9K
Earning Date
N/A
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$290.34
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.21
$15.09
52 Week High
$14.10
$40.47

Technical Indicators

Market Signals
Indicator
LYNX
AAPG
Relative Strength Index (RSI) 52.01 33.66
Support Level $12.21 N/A
Resistance Level N/A $18.45
Average True Range (ATR) 0.77 0.30
MACD 0.08 -0.19
Stochastic Oscillator 81.48 0.00

Price Performance

Historical Comparison
LYNX
AAPG

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: